Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.12
(
0.00%
)
Bitcoin
78,343.94
(
-0.25%
)
News Focus
News Focus

Replies to post #302 on Revance Therapeutics Inc (RVNC)

Replies to #302 on Revance Therapeutics Inc (RVNC)
icon url

DewDiligence

11/30/17 6:30 PM

#303 RE: DewDiligence #302

Refresher on RVNC phase-2 CD data that triggered the decision to advance the CD program to phase-3:

#msg-131479120
#msg-131924083